InvestorsHub Logo
Followers 42
Posts 5506
Boards Moderated 0
Alias Born 01/28/2010

Re: General_Sevier post# 840

Saturday, 06/05/2010 11:35:45 AM

Saturday, June 05, 2010 11:35:45 AM

Post# of 205102
This was announced by Arrayit in Dec 2009, correct?

However, in your post # 780 you quoted Dr Schena saying this:

January 08, 2010

"OvaDx was developed completely in house, Schena said, and is based on a different set of biomarkers than those discovered by Wayne State University researchers for detecting early-stage ovarian cancer and licensed by Arrayit. Last month, the company said that it is partnering with the university scientists to further develop those biomarkers into a microarray-based diagnostic."

Are they working with two sets of biomarkers?